Skip to main content
. 2021 Apr 7;41(4):BSR20204442. doi: 10.1042/BSR20204442

Figure 3. Correlation of our signature with the clinicopathological characteristics of HCC.

Figure 3

(A) Age (≥ 65 vs. <65 years; P=0.4375); (B) Sex (male vs. female; P=0.920); (C) Tumor grade (grade 1-2 vs. 3-4; P=0.032); (D) Tumor stage (stage 3-4 vs. 1-2; P=0.005); (E) Alpha-fetoprotein(AFP) (≤20 vs. >20 ng/ml; P=0.291). (F) Vascular invasion (none vs. micro vs. macro; P=0.030).